Comparing Concussion Education Types
Launched by PIYA SORCAR · Apr 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different ways of teaching about concussions can affect people's understanding and attitudes towards them. Researchers want to see if watching concussion education videos in 2D or in 3D (using virtual reality) makes a difference in how much people know about concussions, how confident they feel reporting them, and how empathetic they are towards those who have experienced one.
To participate, you need to be at least 18 years old and either a health professions student (like nursing or physical therapy) or a student-athlete at Concordia University in Ann Arbor or Mequon. If you haven't seen the TeachAids CrashCourse concussion education before, you can join the study. Participants will watch both types of education materials, either in 2D or 3D, and will help researchers understand which method is more effective. The trial is currently recruiting, and everyone is welcome to join!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age
- • health professions student (ex: Nursing, PT, OT, Pharmacy, Athletic Training) and/or a student-athlete at Concordia University (Ann Arbor or Mequon campus)
- Exclusion Criteria:
- • - have previously viewed the TeachAids CrashCourse concussion education
About Piya Sorcar
Piya Sorcar is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in healthcare innovation and a focus on developing cutting-edge therapies, she leads initiatives that bridge the gap between scientific discovery and clinical application. Sorcar's approach emphasizes collaboration with diverse stakeholders, including academic institutions, healthcare providers, and regulatory bodies, to ensure that trials are designed with rigor and integrity. Her work is characterized by a patient-centered philosophy, driving efforts to enhance the safety and efficacy of new treatments through meticulous research and ethical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mequon, Wisconsin, United States
Patients applied
Trial Officials
Daniel H Daneshvar, MD, PhD
Principal Investigator
TeachAids and Mass General Brigham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported